AI in endoscopy market to hit $36.38B by 2029 at 28.1% CAGR, driven by real-time detection, AI imaging advances, and cloud-based diagnostic tools.
Read More
Anti-tumor drugs market to reach $311.86B by 2029 at 10.8% CAGR, driven by precision medicine, novel therapies, and advances in oncology drug design.
Read More
Antimicrobial resistance diagnostics market to hit $5.82B by 2029 at 7.2% CAGR, driven by rapid tests, stewardship efforts, and advanced detection tech.
Read More
Anti-inflammatory biologics market to reach $166.28B by 2029 at 9% CAGR, driven by targeted therapies, personalized medicine, and biologic innovations.
Read More
Anti-D immunoglobulin market to hit $3.34B by 2029 at 6.6% CAGR, driven by maternal health focus, antenatal care demand, and advances in plasma tech.
Read More
Anti-CD20 monoclonal antibodies market to reach $12.05B by 2029 at 7.6% CAGR, driven by combo therapies, biosimilars, and advanced antibody tech.
Read More
Androgen deprivation therapy market to hit $10.49B by 2029 at 6% CAGR, driven by prostate cancer cases, combo therapies, and advanced drug delivery.
Read More
Ambulance stretcher market to reach $2.84B by 2029 at 6.5% CAGR, driven by EMS demand, aging population, chronic illness rise, and tech innovations.
Read More
Aerosol drug delivery devices market to hit $59.45B by 2029 at 9.4% CAGR, driven by smart inhalers, respiratory disease burden, and eco-friendly tech.
Read More
Advanced therapy medicinal products market to reach $104.43B by 2029 at 19.4% CAGR, driven by precision medicine, gene therapies, and biotech innovation.
Read More